Animal study · Aging · 26 Oct 2026
Seven Mayo papers map senescent cells, including a tomato compound in mice
Source: ScienceDaily
What the research found
ScienceDaily reported on 26 October 2026 a Mayo Clinic package of seven papers, several in Nature journals, on senescent cells that stop dividing but keep releasing inflammatory signals. The set includes a gene-pattern tool, SenMayo, tested in part on bone biopsies from older adults, and work on mitochondrial routes to that inflammatory signal. In older mice, senolytic approaches, a tomato compound called tomatidine, and genetic targeting were linked to lower inflammation and, depending on the experiment, better frailty measures or cognitive-task scores. A blood marker, IL-23R, is proposed only as a research measure. These are lab and mouse findings plus a gene-set methods paper, not a reason to use tomato compounds or senolytic drugs. Not medical advice.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
More aging news
- In middle-aged male mice, an earlier loss of new tumor-fighting immune cells lined up with weaker melanoma control
- A commentary says telomere RNA loops can stall DNA copying and, in some tumors, get used to keep chromosome ends going
- After a long decline, heart-valve death rates in U.S. older adults rose from 2018 to 2023
- In adults over 50 followed for 24 years, a higher body mass index lined up with a faster drop in memory and thinking
- A lab force on bone extended lifespan in older mice through a signal called PEDF